CogMe for the Prevention and Early Detection of Delirium (CogMe)

  • End date
    Jun 30, 2024
  • participants needed
  • sponsor
    Rambam Health Care Campus
Updated on 19 April 2022


This study is designed as a prospective interventional study to evaluate the CogMe system for early detection and prevention of delirium. The study will collect physiological and cognitive measurements to evaluate the ability of the CogMe system to predict and detect delirium and to aid the development of future delirium prevention methods.


Delirium is a syndrome defined as an acute disturbance of both consciousness and cognition that tends to fluctuate over time and is caused by the physiological consequences of a medical condition. It is a common disorder in acute care settings, in internal medicine units, in post-operative patients and the intensive care unit. Delirium is associated with increased mortality, longer hospital stays, long-term cognitive impairment and increased healthcare costs. The pathophysiology of delirium is multifactorial and is not completely understood.

The prevalence of delirium increases with age and is very common in elderly hospitalized patients. In certain departments delirium rates can reach over 40%. However, delirium is underdiagnosed in almost two thirds of cases or misdiagnosed as depression or dementia. Furthermore, it has been previously shown that the diagnosis of delirium is often delayed, and that the recognition and documentation of delirium by physicians and nurses is far from optimal. Early diagnosis of delirium may improve clinical outcome, with shortened duration of symptoms, decreased length of admission and reduced long-term complications.

Clinical studies have demonstrated that delirium may be prevented in up to one-third of cases by multifactored non-pharmacological interventions, yet they can be costly to implement and require specially trained staff members. In addition, they do not usually consider physiological parameters.

Three recent technological advances now provide opportunities for a new delirium prevention approach. First, over the recent years vital signs monitoring with wearable sensors powered by advanced processing algorithms has become technically feasible. This development may provide opportunities for early detection of delirium and for detection of physiological triggers of delirium such as dehydration, infections, and lack of sleep. Second, recent advances in virtual dialogue systems (e.g. Amazon's Alexa or Apple's Siri) provide new and exciting opportunities for automatic patient interaction. Devices with voice or multimodal communication can be used by older patients with little or no experience in modern mobile technology. Lastly, recent progress in digitized data acquisition, computing infrastructure and algorithm development, now allow artificial intelligence and machine learning applications to expand into areas in medicine that were previously thought to be only the province of human experts. The combination of these three data sources can greatly improve current prediction models and allow for earlier and more accurate delirium prediction.

An automated system which could aid with delirium detection and alert clinicians to a possible onset of the syndrome can greatly improve treatment and outcomes for patients. The CogMe system utilizes current technology to provide a holistic and scalable approach for delirium prediction, detection and prevention covering both physiological and cognitive aspects. The system uses wearables for physiological vitals monitoring and communicates with patients by a dedicated tablet app - the CogMe Personal Assistant (PA). In this study, the data collected by the wearables and the CogMe PA, in combination with patient data from the EMR, will be analyzed retrospectively using machine learning techniques (CogMe Data Analytics) to evaluate the ability of the CogMe system to predict and detect delirium.

Condition Delirium
Treatment CogMe Personal Assistant (PA)
Clinical Study IdentifierNCT05311761
SponsorRambam Health Care Campus
Last Modified on19 April 2022


Yes No Not Sure

Inclusion Criteria

Male and female patients aged 65 years of age and older
Patients with an expected length of hospitalization of 4 days or longer
Patients who are conscious and cognitively able to provide written informed consent as suggested by a score of 0 on 4AT screening
Patients who have no diagnosis of delirium prior to enrollment

Exclusion Criteria

Male and female patients younger than 65 years of age
Patients with an expected length of hospitalization of less than 4 days
Patients with uncorrected visual or hearing impairment
Patients with impaired consciousness or cognitive impairment as determined by a score of 1 or more on 4AT screening
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note